NCT05927870 is a NA clinical trial of pigtail in Gall Bladder Disease, sponsored by Assiut University.

Who is sponsoring NCT05927870?

NCT05927870 is sponsored by Assiut University.

What drugs are being tested in NCT05927870?

Interventions in NCT05927870: pigtail.

What condition does NCT05927870 study?

NCT05927870 studies Gall Bladder Disease.

Is NCT05927870 still recruiting?

NCT05927870 is currently status unknown. Last updated 14 July 2023.

Last reviewed 2023-07-14 · How we verify

NCT05927870

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound Guided Percutaneous Cholecystostomy.

Status unknown NA Last updated 14 July 2023

What this trial tests

NA trial testing pigtail in Gall Bladder Disease in 50 participants. Status unknown.

Timeline

1 August 2023

Primary endpoint
1 July 2024

1 September 2024

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 August 2023
Primary completion	1 July 2024
Estimated completion	1 September 2024

Drugs / interventions tested

pigtail

Conditions studied

Gall Bladder Disease — all drugs for Gall Bladder Disease →

Sponsor

Assiut University

Who can join

Adults 4 to 100, any sex, with Gall Bladder Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgical cholecystostomy has proven value in the management of both inflammatory and obstructive biliary tract disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05927870 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 14 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05927870.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing